Swiss Atrial Fibrillation Cohort Study
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 2600
Summary
- Conditions
- Atrial Fibrillation
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 45 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT02105844
- Collaborators
- Swiss National Science Foundation
- Medical Image Analysis Center (MIAC) Basel
- Schiller AG Baar
- Clinical Trial Unit, University Hospital Basel, Switzerland
- Cardiovascular Research Institute (CRIB) Basel
- Cardiocentro Ticino
- Investigators
- Study Director: Stefan Osswald, MD, Prof. University Hospital, Basel, Switzerland Principal Investigator: Michael Kuehne, MD, PD, exec. MBA University Hospital, Basel, Switzerland Principal Investigator: David Conen, MD MPH McMaster University, Population Health Research Institute, Hamilton, Canada
Get Well Soon